Quick Comparison
| NAC (N-Acetyl Cysteine) | Noopept | |
|---|---|---|
| Half-Life | 5.6 hours | 30-60 minutes (active metabolite cycloprolylglycine persists longer) |
| Typical Dosage | Standard: 600-1800 mg daily in 2-3 divided doses. For psychiatric applications: 1200-2400 mg daily (under medical supervision). Take on an empty stomach for best absorption. Can cause nausea — take with a small amount of food if needed. | Standard: 10-30 mg sublingually or orally, 2-3 times daily. Sublingual administration provides faster onset. Do not exceed 30 mg per dose. |
| Administration | Oral (capsules, powder). Take on empty stomach or with light food. Effervescent tablets also available. | Oral or sublingual (sublingual preferred for faster onset and higher bioavailability). Available as powder, capsules, or sublingual tablets. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
NAC (N-Acetyl Cysteine)
NAC provides cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via gamma-glutamylcysteine ligase (GCLC) and glutathione synthetase (GSS). GSH is the primary intracellular antioxidant, essential for GPx and GST-mediated detoxification of reactive oxygen species in neurons. NAC also modulates glutamate via the cystine-glutamate antiporter (System Xc-, composed of xCT and 4F2hc) — NAC is deacetylated to cysteine, which exchanges for glutamate; the increased extracellular cystine is reduced to cysteine intracellularly, while the exchange increases extrasynaptic glutamate, which activates inhibitory mGlu2/3 autoreceptors on presynaptic terminals, reducing excessive glutamatergic signaling and compulsive behaviors. This glutamate modulation is the basis for psychiatric applications (OCD, addiction). NAC may also directly modulate NMDA receptors via redox sites.
Noopept
Noopept modulates AMPA and NMDA receptors similarly to racetams through positive allosteric modulation. Its key distinguishing feature is upregulation of BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) via activation of TrkB and TrkA receptor signaling cascades — these neurotrophins are essential for neuronal growth, survival, dendritic arborization, and synaptic plasticity. Noopept inhibits glutamate-induced excitotoxicity by reducing calcium influx through NMDA receptors and modulating the NR2B subunit. It activates the PI3K/Akt and MAPK/ERK pathways downstream of neurotrophin receptors. The active metabolite cycloprolylglycine (a cyclic dipeptide) has endogenous nootropic activity, potentially acting as a trace amine-associated receptor ligand. Neuroprotection is further mediated through antioxidant effects and mitochondrial stabilization.
Risks & Safety
NAC (N-Acetyl Cysteine)
Common
Nausea, diarrhea, unpleasant sulfur smell/taste.
Serious
May be harmful in certain contexts — there is concern it could protect cancer cells from oxidative stress. May interact with nitroglycerin (dangerous blood pressure drop).
Rare
Bronchospasm in asthmatics (when inhaled).
Noopept
Common
Headache (especially without choline supplementation), irritability at higher doses, brain fog in some users.
Serious
No serious adverse effects documented.
Rare
Emotional blunting at high doses, insomnia, allergic reactions.
Full Profiles
NAC (N-Acetyl Cysteine) →
The acetylated form of the amino acid L-cysteine and the most effective oral supplement for raising glutathione — the body's master antioxidant. NAC has an unusually broad range of evidence-based applications: it is used as a prescription drug for acetaminophen overdose, as a mucolytic, and as an adjunct treatment for OCD, addiction, and bipolar disorder. In nootropics, it protects neurons from oxidative stress and modulates glutamate.
Noopept →
A synthetic peptide-derived nootropic often grouped with racetams due to similar effects, though it is technically a dipeptide analog of piracetam. Roughly 1000x more potent by weight than piracetam, requiring only 10-30 mg per dose. It provides both immediate cognitive enhancement and long-term neuroprotective benefits through BDNF and NGF upregulation.